HCA Healthcare [HCA] vs Ensign Group [ENSG] Detailed Stock Comparison
HCA Healthcare
NYSE
Loading...
Ensign Group
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: HCA Healthcare wins in 18 metrics, Ensign Group wins in 2 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | HCA Healthcare | Ensign Group | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.02 | 28.65 | HCA Healthcare |
| Price-to-Book Ratio | -72.79 | 4.49 | HCA Healthcare |
| Debt-to-Equity Ratio | -37.45 | 100.93 | HCA Healthcare |
| PEG Ratio | 15.54 | 25.75 | HCA Healthcare |
| EV/EBITDA | 9.37 | 21.80 | HCA Healthcare |
| Profit Margin (TTM) | 8.21% | 7.00% | HCA Healthcare |
| Operating Margin (TTM) | 15.95% | 8.46% | HCA Healthcare |
| EBITDA Margin (TTM) | 15.95% | 8.46% | HCA Healthcare |
| Return on Equity | 13,631.68% | 17.54% | HCA Healthcare |
| Return on Assets (TTM) | 11.84% | 5.30% | HCA Healthcare |
| Free Cash Flow (TTM) | $5.64B | $188.95M | HCA Healthcare |
| Dividend Yield | 0.54% | 0.20% | HCA Healthcare |
| 1-Year Return | 5.74% | 13.83% | Ensign Group |
| Price-to-Sales Ratio (TTM) | 1.23 | 1.98 | HCA Healthcare |
| Enterprise Value | $135.84B | $10.68B | HCA Healthcare |
| EV/Revenue Ratio | 1.87 | 2.32 | HCA Healthcare |
| Gross Profit Margin (TTM) | 40.97% | 16.19% | HCA Healthcare |
| Revenue per Share (TTM) | $292 | $81 | HCA Healthcare |
| Earnings per Share (Diluted) | $23.82 | $5.52 | HCA Healthcare |
| Beta (Stock Volatility) | 1.40 | 1.02 | Ensign Group |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
HCA Healthcare vs Ensign Group Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HCA Healthcare | 2.22% | 6.90% | 1.06% | 7.82% | 19.91% | 28.16% |
| Ensign Group | 0.86% | 5.85% | 10.15% | 17.87% | 24.30% | 20.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HCA Healthcare | 5.74% | 74.34% | 183.87% | 317.52% | 1,126.25% | 1,126.25% |
| Ensign Group | 13.83% | 83.05% | 189.50% | 609.89% | 3,481.07% | 3,802.67% |
Performance & Financial Health Analysis: HCA Healthcare vs Ensign Group
| Metric | HCA | ENSG |
|---|---|---|
| Market Information | ||
| Market Cap | $89.29B | $9.12B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,426,893 | 616,200 |
| 90 Day Avg. Volume | 1,471,124 | 431,840 |
| Last Close | $381.61 | $160.63 |
| 52 Week Range | $289.98 - $417.14 | $118.73 - $162.05 |
| % from 52W High | -8.52% | -0.88% |
| All-Time High | $417.14 (Oct 14, 2024) | $162.05 (Aug 08, 2025) |
| % from All-Time High | -8.52% | -0.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.19% |
| Quarterly Earnings Growth | 0.13% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.07% |
| Operating Margin (TTM) | 0.16% | 0.08% |
| Return on Equity (TTM) | 136.32% | 0.18% |
| Debt to Equity (MRQ) | -37.45 | 100.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-18.61 | $35.23 |
| Cash per Share (MRQ) | $4.45 | $7.30 |
| Operating Cash Flow (TTM) | $11.93B | $462.89M |
| Levered Free Cash Flow (TTM) | $5.59B | $30.01M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.54% | 0.20% |
| Last 12-Month Dividend | $2.04 | $0.30 |
Valuation & Enterprise Metrics Analysis: HCA Healthcare vs Ensign Group
| Metric | HCA | ENSG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.02 | 28.65 |
| Forward P/E | 15.54 | 25.75 |
| PEG Ratio | 15.54 | 25.75 |
| Price to Sales (TTM) | 1.23 | 1.98 |
| Price to Book (MRQ) | -72.79 | 4.49 |
| Market Capitalization | ||
| Market Capitalization | $89.29B | $9.12B |
| Enterprise Value | $135.84B | $10.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.87 | 2.32 |
| Enterprise to EBITDA | 9.37 | 21.80 |
| Risk & Other Metrics | ||
| Beta | 1.40 | 1.02 |
| Book Value per Share (MRQ) | $-18.61 | $35.23 |
Financial Statements Comparison: HCA Healthcare vs Ensign Group
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HCA | ENSG |
|---|---|---|
| Revenue/Sales | $18.61B | $1.23B |
| Cost of Goods Sold | $10.98B | $1.03B |
| Gross Profit | $7.62B | $198.79M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $2.97B | $103.90M |
| EBITDA | $3.85B | $140.17M |
| Pre-Tax Income | $2.42B | $112.36M |
| Income Tax | $524.00M | $27.89M |
| Net Income (Profit) | $1.89B | $84.47M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HCA | ENSG |
|---|---|---|
| Cash & Equivalents | $1.06B | $282.67M |
| Total Current Assets | $16.26B | $986.39M |
| Total Current Liabilities | $13.63B | $705.21M |
| Long-Term Debt | $42.92B | $1.91B |
| Total Shareholders Equity | $-438.00M | $1.93B |
| Retained Earnings | $-3.16B | $1.50B |
| Property, Plant & Equipment | $65.81B | $2.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HCA | ENSG |
|---|---|---|
| Operating Cash Flow | $2.65B | $97.90M |
| Capital Expenditures | $-991.00M | $-42.93M |
| Free Cash Flow | $660.00M | $29.29M |
| Debt Repayment | $-3.90B | $-1.01M |
| Common Stock Repurchase | $-2.51B | $-10.79M |
Short Interest & Institutional Ownership Analysis
| Metric | HCA | ENSG |
|---|---|---|
| Shares Short | 3.89M | 1.87M |
| Short Ratio | 2.67 | 5.73 |
| Short % of Float | 0.02% | 0.04% |
| Average Daily Volume (10 Day) | 1,426,893 | 616,200 |
| Average Daily Volume (90 Day) | 1,471,124 | 431,840 |
| Shares Outstanding | 249.98M | 57.44M |
| Float Shares | 161.55M | 55.24M |
| % Held by Insiders | 0.31% | 0.03% |
| % Held by Institutions | 0.68% | 0.94% |
Dividend Analysis & Yield Comparison: HCA Healthcare vs Ensign Group
| Metric | HCA | ENSG |
|---|---|---|
| Last 12-Month Dividend | $2.04 | $0.30 |
| Last 12-Month Dividend Yield | 0.54% | 0.20% |
| 3-Year Avg Annual Dividend | $2.29 | $0.26 |
| 3-Year Avg Dividend Yield | 0.22% | 0.05% |
| 3-Year Total Dividends | $6.88 | $0.78 |
| Ex-Dividend Date | Mar 17, 2025 | Jun 30, 2025 |